Allspring Global Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,325
Closed -$80.9K 2908
2023
Q1
$80.9K Sell
3,325
-1,952
-37% -$42.7K ﹤0.01% 2123
2022
Q4
$113K Sell
5,277
-116
-2% -$2.48K ﹤0.01% 2031
2022
Q3
$96K Sell
5,393
-4,472
-45% -$58.7K ﹤0.01% 2104
2022
Q2
$94K Sell
9,865
-32,570
-77% -$409K ﹤0.01% 2088
2022
Q1
$714K Buy
42,435
+6,128
+17% +$90.6K ﹤0.01% 2061
2021
Q4
$607K Buy
+36,307
New +$595K ﹤0.01% 2216

Other funds holding ISEE

Allspring Global Investments's ISEE Position: Q2 2023 in Review

Allspring Global Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 3,325 shares — an estimated $80.9K sold.

Allspring Global Investments first reported a position in ISEE in Q4 2021 and held it in 6 quarters. The position peaked at $714K in Q1 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Allspring Global Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Allspring Global Investments sold 3,325 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $80.9K.
  • Allspring Global Investments first reported a position in IVERIC bio, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's IVERIC bio, Inc. Common Stock position peaked at $714K in Q1 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.